| Literature DB >> 35028168 |
Hea-Sun Chun1, Dong-Hwan Kim2, Ho-Seub Song1.
Abstract
OBJECTIVES: The aim of this review was to appraise Korean studies published between 2010 and 2021 which examined the role of acupuncture in the treatment of obesity.Entities:
Keywords: acupuncture; local obesity; obesity treatment; review
Year: 2021 PMID: 35028168 PMCID: PMC8716705 DOI: 10.3831/KPI.2021.24.4.173
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
Figure 1Reference flow chart.
Figure 2Classifications of acupuncture type. PA, Pharmacopuncture; MA, Manual Acupuncture; EA, Electronic Acupuncture; AP, Acupotomy; TE, Tread-Embedding; AU, Auricular Acupuncture.
Figure 3Summary of acupuncture type according to the research type. PA, Pharmacopuncture; MA, Manual Acupuncture; EA, Electronic Acupuncture; AP, Acupotomy; TE, Tread-Embedding; AU, Auricular Acupuncture; CO, Combined Treatment.
Figure 5Classifications of study.
Classifications of animal research
| Study/Year | Treatment | Injections | Acupoint/Injection Point |
|---|---|---|---|
| Kwon (2010) [ | Pharmacopuncture |
| CV12, ST36 |
| Park (2010) [ | Pharmacopuncture |
| CV13 |
| Youh (2010) [ | Pharmacopuncture |
| BL23 |
| Lee (2010) [ | Pharmacopuncture |
| ST25 |
| Youh (2011) [ | Pharmacopuncture |
| BL20 |
| Ryu (2012) [ | Pharmacopuncture |
| BL20 |
| Kim (2012) [ | Pharmacopuncture |
| BL23 |
| Kim (2013) [ | Pharmacopuncture | Intraperitoneal/Subcutaneous | |
| Roh (2013) [ | Pharmacopuncture |
| Intraperitoneal/Subcutaneous |
| Ryu (2013) [ | Pharmacopuncture |
| LR14 |
| Kim (2014) [ | Pharmacopuncture | Pericarpium Zanthixyli, Ephedrasinica Staph Aconitum carmichaeliDebeaux and Cultivated Wild Ginseng | BL20 |
| Koo (2016) [ | Pharmacopuncture | Cultivated Ginseng, Wild Ginseng,Red Ginseng | BL13 |
| Kim (2016) [ | Pharmacopuncture |
| Subcutaneous |
| Seol (2016) [ | Pharmacopuncture |
| Subcutaneous |
| Cheong (2017) [ | Pharmacopuncture |
| CV12 |
| Lee (2020) [ | Pharmacopuncture |
| Inguinal fat |
| Nam (2021) [ | Pharmacopuncture |
| Inguinal fat |
| Woo (2014) [ | Manual Acupuncture |
| HT7, ST36 |
| Combined treatment | |||
| Bang (2011) [ | Pharamcopuncture/ |
| BL21 |
Classifications of case study
| Study/Year | Treatment | N | Obesity | Acupoint/Injection point |
|---|---|---|---|---|
| Go (2015) [ | EA | 3 | Obesity | Thigh area |
| Shin (2011) [ | TE | 9 | Localized obesity | Forearm, Thigh, Abdominal |
| Shin (2012) [ | TE | 5 | Localized obesity | Forearm, Thigh, Abdominal |
| Hwang (2018) [ | PA | 2 | Localized obesity | Abdominal area |
| Combined treatment | ||||
| Shin (2013) [ | PA/TE | 5 | Abdominal obesity | ST25, CV5, CV4, CV3 (PP); ST25-CV8 (TE) |
| Chon (2015) [ | PA/TE | 5 | Localized obesity | ST25, CV8, CV6, CV4, CV3, CV9, CV12,BL36, BL57, BL58, BL59 |
| Yun (2015) [ | MA/EA | 6 | Abdominal obesity | CV12, CV6, ST25, ST21, SP15, SP14, CV8, LI4, LI11,ST36, ST44 (MA); ST21, SP14, ST25, CV8 (EA) |
| Cho (2017) [ | AP/CT/HM | 24 | Localized obesity | Subcutaneous fat |
| Yoon (2015) [ | AP/CT | 4 | Localized obesity | Subcutaneous fat |
| Park (2016) [ | PA/Moxa | 5 | Abdominal obesity | CV10, CV4, ST25, ST27, SP15, SP14 |
| Yoo (2016) [ | PA/HS | 2 | Abdominal obesity (woman) | CV6, CV4, ST25, ST28, SP15, SP14 |
| Jung (2011) [ | EA/AU/Moxa/HM | 1 | Child obesity | Abdominal, LI4, LI11, ST36, ST38, ST40, LR3 (EA);CV12, CV4 (MOXA); Shenmen, Spleen, Stomach,Endocrine, Hunger point (AU) |
PA, Pharmacopuncture; TE, Thread-Embedding; MA, Manual Acupuncture; EA, Electroacupuncture; AU, Auricular Acupuncture; AP, Acupotomy; CT, Cold Therapy; HM, Herbal Medicine; Moxa, Moxibustion; HS, Heat Stimulus.
Classifications of clinical trial
| Study/Year | Treatment | N (group) | Obesity | Acupoint/Injection point |
|---|---|---|---|---|
| Song (2010) [ | EA | 10 | Abdominal obesity | Abdominal, Subcutaneous fat |
| Chung (2010) [ | EA | 35 (EA group 12, sham EA group11, waitlist group 12) | Abdominal obesity | CV12, CV6, ST25, SP15, SP14,LI4, LI11, ST36, ST44 |
| Oh (2017) [ | EA | 12 (Insulated needle group 5,control group 7) | Abdominal obesity | CV12, CV6, ST25, ST27, SP15 |
| Yeo (2014) [ | AU | 58 (Five AU group 22, Hunger AUgroup 21, Sham control group 15) | Overweight | Shenmen, Spleen, Stomach,Hunger, Endocrine |
| Kim (2016) [ | MA/EA | 37 | Obesity (woman) | LI4, LI11, SP6, ST36, CV12,CV6 (MA); ST25, ST28 (EA) |
| Shin (2018) [ | MA/EA | 91 (Acupuncture group 48, Sham-acupuncture control group 43) | Obesity (woman) | LI4, LI11, SP6, ST36, CV6,CV12 (MA); ST25, ST28 (EA) |
| Kim (2021) [ | MA/EA | 91 (Treatment group 48, Controlgroup 43) | Obesity (woman) | LI4, LI11, SP6, ST36, CV6,CV12 (MA); ST25, ST28 (EA) |
MA, Manual Acupuncture; EA, Electroacupuncture; AU, Auricular Acupuncture.
Summary of study
| Subject | Study | Acupuncture type | N | % | |
|---|---|---|---|---|---|
| Animal | Animal research | PA [ | 17 | 44 | |
| MA [ | 1 | 3 | |||
| Combined treatment | PA + HM [ | 1 | 3 | ||
| Human | Case study | TE [ | 2 | 6 | |
| PA [ | 1 | 3 | |||
| Combined treatment | PA + TE [ | 9 | 23 | ||
| PA + Moxa [ | |||||
| PA + HS [ | |||||
| AP + CT [ | |||||
| AP + CT + HM [ | |||||
| EA + HM [ | |||||
| EA + AU + Moxa + HM [ | |||||
| MA + EA [ | |||||
| Clinical trial | EA [ | 3 | 7.5 | ||
| AU [ | 1 | 3 | |||
| Combined treatment | MA + EA [ | 3 | 7.5 | ||
| - | Total | - | 38 | 100 | |
PA, Pharmacopuncture; HM, Herbal Medicine; TE, Thread-Embedding; HS, Heat Stimulus; CT, Cold Therapy; EA, Electroacupuncture; AU, Auricular Acupuncture; Moxa, Moxibustion; MA, Manual Acupuncture; AP, Acupotomy.